Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30426297 | 1.00 | ACHE (0.38) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| SCHEMBL2154086 | 0.85 | CYP3A4 (0.36) | ACHENFE2L2ALDH1A1ALOX15 | |
| SCHEMBL29534836 | 0.85 | CYP3A4 (0.36) | ACHENFE2L2ALDH1A1ALOX15 | |
| SCHEMBL1041344 | 0.83 | ACHE (0.38) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| SCHEMBL476837 | 0.77 | ACHE (0.41) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| SCHEMBL30700143 | 0.77 | ACHE (0.41) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| Hydrochloric Acid SCHEMBL11570761 | 0.74 | ACHE (0.39) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| Hydrochloric Acid SCHEMBL11570767 | 0.74 | ACHE (0.39) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| SCHEMBL15272385 | 0.72 | ACHE (0.38) | ACHENFE2L2ALDH1A1ALOX15CES2 | |
| SCHEMBL12620592 | 0.72 | CES2 (0.39) | ACHENFE2L2ALDH1A1ALOX15CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113896607-B | Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-3907004-B1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF, CATALYST COMPOSITION, AND ETHYLENE OLIGOMERIZATION, TRIMERIZATION AND TETRAMERIZATION METHODS | CHINA PETROLEUM & CHEM CORP (CN) | 2023-09-13 | — | — | EP | disclosed |
| CN-107548385-B | Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113896607-A | Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2022-01-07 | — | — | CN | disclosed |
| EP-3907004-A1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF, CATALYST COMPOSITION, AND ETHYLENE OLIGOMERIZATION, TRIMERIZATION AND TETRAMERIZATION METHODS | China Petroleum & Chemical Corporation (CN) | 2021-11-10 | — | — | EP | disclosed |
| CN-107592863-B | Chromium complexes with ligands containing phosphacycles and olefin oligomerization catalysts therefrom | 陶氏环球技术有限责任公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-107567355-B | Phosphacycle-containing ligands for chromium complexes and olefin oligomerization catalysts therefrom | 陶氏环球技术有限责任公司 | 2021-07-23 | — | — | CN | disclosed |
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-06 | — | — | US | disclosed |
| US-10981156-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10919031-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-02-16 | — | — | US | disclosed |
| WO-2015083053-A1 | ETHYLENE OLIGOMERIZATION WITH MIXED LIGANDS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2015-06-11 | — | — | WO | disclosed |
| US-20150080629-A1 | Tetramerisation of Ethylene | SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) | 2015-03-19 | — | — | US | disclosed |
| US-20140221645-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-08-07 | — | — | US | disclosed |
| US-8680003-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120309965-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-12-06 | — | — | US | disclosed |
| EP-2519532-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | Chevron Phillips Chemical Company LP (US) | 2012-11-07 | — | — | EP | disclosed |
| WO-2011082192-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-07-07 | — | — | WO | disclosed |
| EP-2277623-A2 | Polymeric phosphorus-containing compositions and their use in hydrocyanation, unsaturated nitrile isomerization and hydroformylation reactions | INVISTA Technologies S.à.r.l. (CH) | 2011-01-26 | — | — | EP | disclosed |
| EP-1448298-B1 | POLYMERIC PHOSPHORUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, UNSATURATED NITRILE ISOMERIZATION AND HYDROFORMYLATION REACTIONS | INVISTA TECH SARL (CH) | 2010-09-22 | — | — | EP | disclosed |
| EP-1905511-A2 | Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions | INVISTA Technologies S.à.r.l. (CH) | 2008-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | ACHE 307/4885NFE2L2 256/4885ALDH1A1 4182/4885 |
| US-10919031-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | ACHE 307/4885NFE2L2 256/4885ALDH1A1 4182/4885 |
| US-20120309965-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | NIT2, NCLN, NPM1 | ACHE 1107/4885NFE2L2 3797/4885ALDH1A1 4849/4885 |
| US-10981156-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ACHE 110/4885NFE2L2 33/4885ALDH1A1 4013/4885 |
| US-20140221645-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | NIT2, NCLN, NPM1 | ACHE 1107/4885NFE2L2 3797/4885ALDH1A1 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.